BusinessVersalis and Genomatica Produce Bio-Rubber With Bio-Butadiene From SugarsBy Nasdaq OMXFeb 16, 2016, 11:00 AM UTC
BusinessArQule to Report Fourth Quarter and Full Year 2015 Financial Results on February 29, 2016By Nasdaq OMXFeb 15, 2016, 12:30 PM UTC
BusinessuniQure to Present at the RBC Capital Markets 2016 Global Healthcare ConferenceBy Nasdaq OMXFeb 15, 2016, 10:00 AM UTC
BusinessZealand doses the first patients with ZP1848 for short bowel syndrome, advancing the second of its proprietary specialty medicines into Phase II development in 2016By Nasdaq OMXFeb 15, 2016, 7:38 AM UTC
BusinessNewLink Genetics to Host Its Fourth Quarter and Year End 2015 Financial Results Conference Call on February 29, 2016By Nasdaq OMXFeb 12, 2016, 12:00 PM UTC
BusinessBiofrontera AG: Pivotal Phase III Data Demonstrate Significant Efficacy and Excellent Safety for BF-200 ALA Treatment of Superficial Skin CancerBy Nasdaq OMXFeb 11, 2016, 3:37 PM UTC
BusinessAchillion Initiates Phase 1 Study of ACH-4471, First Orally-Administered Small Molecule Complement Factor D InhibitorBy Nasdaq OMXFeb 11, 2016, 11:05 AM UTC
